CN104666777A - Medicine for treating coronary heart disease - Google Patents
Medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN104666777A CN104666777A CN201310642374.9A CN201310642374A CN104666777A CN 104666777 A CN104666777 A CN 104666777A CN 201310642374 A CN201310642374 A CN 201310642374A CN 104666777 A CN104666777 A CN 104666777A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma atractylodis
- heart disease
- coronary heart
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating a coronary heart disease, belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine for treating the coronary heart disease. The invention provides the traditional Chinese medicine for treating the coronary heart disease, and the medicine is high in efficiency and can be used for completely curing the coronary heart disease. The traditional Chinese medicine for treating the coronary heart disease is characterized by being prepared from 2-8 parts of rhizoma atractylodis, 2-8 parts of apricot kernels, 2-8 parts of yellow rhizoma atractylodis, 3-9 parts of radix achyranthis bidentatae, 3-9 parts of spora lygodii, 3-9 parts of aloe and 4-12 parts of olive.
Description
Technical field
The invention belongs to technical field of Chinese medicine, specifically, the present invention relates to a kind of Chinese medicine for the treatment of coronary heart disease.
Background technology
Coronary heart disease is called for short coronary heart disease.Refer to that, because lipid metabolism is abnormal, the lipid in blood is calm on the endarterium of otherwise smooth, pile up at the lipid material of some similar medicated porridge samples of endarterium and form white speckle, be called atherosclerotic lesion.These specklees gradually increase and cause lumen of artery narrow, blood flow is obstructed, causes heart ischemia, produce angina pectoris.
Summary of the invention
The present invention is exactly for above-mentioned technical problem, provides a kind of effective percentage high, can cure the Chinese medicine of the treatment coronary heart disease of coronary heart disease completely.
For realizing above-mentioned purpose of the present invention, the present invention adopts following technical scheme: the Chinese medicine for the treatment of coronary heart disease of the present invention, is characterized in that: be made up of Rhizoma Atractylodis 2-8 part, Fructus Lycii 2-8 part, the yellow 2-8 part of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3-9 part, Spora Lygodii 3-9 part, Aloe 3-9 part, Fructus Canarii albi 4-12 part.
Beneficial effect of the present invention: flavour of a drug of the present invention are few, and cost of drugs is cheap, is easy to configuration; And have no side effect, curative effect is good, cures speed soon, the object of radical cure coronary heart disease can be reached.
The present invention is through clinical verification, and effective percentage reaches 100%, and cure rate reaches more than 95%.
Detailed description of the invention
The Chinese medicine for the treatment of coronary heart disease of the present invention, is characterized in that: be made up of Rhizoma Atractylodis 2-8 part, Fructus Lycii 2-8 part, the yellow 2-8 part of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3-9 part, Spora Lygodii 3-9 part, Aloe 3-9 part, Fructus Canarii albi 4-12 part.
Embodiment 1: be made up of Rhizoma Atractylodis 2 parts, Fructus Lycii 2 parts, yellow 2 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3 parts, Spora Lygodii 3 parts, Aloe 3 parts, Fructus Canarii albi 4 parts.
Embodiment 2: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 9 parts, Spora Lygodii 9 parts, Aloe 9 parts, Fructus Canarii albi 12 parts.
Embodiment 3: be made up of Rhizoma Atractylodis 3 parts, Fructus Lycii 3 parts, yellow 3 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3 parts, Spora Lygodii 3 parts, Aloe 3 parts, Fructus Canarii albi 4 parts.
Embodiment 4: be made up of Rhizoma Atractylodis 4 parts, Fructus Lycii 4 parts, yellow 4 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 4 parts, Spora Lygodii 4 parts, Aloe 4 parts, Fructus Canarii albi 4 parts.
Embodiment 5: be made up of Rhizoma Atractylodis 5 parts, Fructus Lycii 5 parts, yellow 5 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 5 parts, Spora Lygodii 5 parts, Aloe 5 parts, Fructus Canarii albi 5 parts.
Embodiment 6: be made up of Rhizoma Atractylodis 6 parts, Fructus Lycii 6 parts, yellow 6 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 6 parts, Spora Lygodii 6 parts, Aloe 6 parts, Fructus Canarii albi 6 parts.
Embodiment 7: be made up of Rhizoma Atractylodis 7 parts, Fructus Lycii 7 parts, yellow 7 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 7 parts, Spora Lygodii 7 parts, Aloe 7 parts, Fructus Canarii albi 7 parts.
Embodiment 8: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 8 parts, Spora Lygodii 8 parts, Aloe 8 parts, Fructus Canarii albi 8 parts.
Embodiment 9: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 9 parts, Spora Lygodii 9 parts, Aloe 9 parts, Fructus Canarii albi 12 parts.
Case: patient age: 58 years old, use the embodiment of the present invention 1 compounding pharmaceutical, 2 as a child, namely has the effect of obvious mitigation symptoms, 24 hours, and symptom basic solution removes.After January, can fully recover, without repeatedly, have no side effect.
Claims (10)
1. treat a medicine for coronary heart disease, it is characterized in that: be made up of Rhizoma Atractylodis 2-8 part, Fructus Lycii 2-8 part, the yellow 2-8 part of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3-9 part, Spora Lygodii 3-9 part, Aloe 3-9 part, Fructus Canarii albi 4-12 part.
2. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 2 parts, Fructus Lycii 2 parts, yellow 2 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3 parts, Spora Lygodii 3 parts, Aloe 3 parts, Fructus Canarii albi 4 parts.
3. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 9 parts, Spora Lygodii 9 parts, Aloe 9 parts, Fructus Canarii albi 12 parts.
4. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 3 parts, Fructus Lycii 3 parts, yellow 3 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 3 parts, Spora Lygodii 3 parts, Aloe 3 parts, Fructus Canarii albi 4 parts.
5. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 4 parts, Fructus Lycii 4 parts, yellow 4 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 4 parts, Spora Lygodii 4 parts, Aloe 4 parts, Fructus Canarii albi 4 parts.
6. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 5 parts, Fructus Lycii 5 parts, yellow 5 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 5 parts, Spora Lygodii 5 parts, Aloe 5 parts, Fructus Canarii albi 5 parts.
7. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 6 parts, Fructus Lycii 6 parts, yellow 6 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 6 parts, Spora Lygodii 6 parts, Aloe 6 parts, Fructus Canarii albi 6 parts.
8. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 7 parts, Fructus Lycii 7 parts, yellow 7 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 7 parts, Spora Lygodii 7 parts, Aloe 7 parts, Fructus Canarii albi 7 parts.
9. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 8 parts, Spora Lygodii 8 parts, Aloe 8 parts, Fructus Canarii albi 8 parts.
10. a kind of medicine for the treatment of coronary heart disease according to claim 1, is characterized in that: be made up of Rhizoma Atractylodis 8 parts, Fructus Lycii 8 parts, yellow 8 parts of Rhizoma Atractylodis, Radix Achyranthis Bidentatae 9 parts, Spora Lygodii 9 parts, Aloe 9 parts, Fructus Canarii albi 12 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310642374.9A CN104666777A (en) | 2013-11-28 | 2013-11-28 | Medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310642374.9A CN104666777A (en) | 2013-11-28 | 2013-11-28 | Medicine for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104666777A true CN104666777A (en) | 2015-06-03 |
Family
ID=53302713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310642374.9A Pending CN104666777A (en) | 2013-11-28 | 2013-11-28 | Medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104666777A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111529616A (en) * | 2020-05-28 | 2020-08-14 | 郭福荣 | Traditional Chinese medicine for treating heart disease |
-
2013
- 2013-11-28 CN CN201310642374.9A patent/CN104666777A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111529616A (en) * | 2020-05-28 | 2020-08-14 | 郭福荣 | Traditional Chinese medicine for treating heart disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103479970B (en) | External medicine for treating rheumatic arthralgia | |
| CN104666777A (en) | Medicine for treating coronary heart disease | |
| CN103417929A (en) | Traditional Chinese medicine for treating children's wind-heat cold | |
| CN102357127A (en) | Chinese herbal medicine for treating influenza | |
| CN102397371A (en) | Medicament for treating stomach illness | |
| CN103656129A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN106581598A (en) | Asthma treatment traditional Chinese medicine prescription | |
| CN104161900A (en) | Traditional Chinese medicine for treating filariasis | |
| CN105497392A (en) | Traditional Chinese medicine formula for treating dyspepsia in the type of liver-stomach disharmony | |
| CN103417596A (en) | Traditional Chinese medicine for treating chronic gastric ulcer | |
| CN103599446B (en) | A kind of Chinese medicine oral liquid with relieving fever and suppressing cough effect | |
| CN103417933A (en) | Traditional Chinese medicine for treating acute wind-cold-caused cough | |
| CN102743496B (en) | A kind of rheumatism type lumbago and skelalgia Chinese medicine plaster | |
| CN105561218A (en) | Asthma treating traditional Chinese medicine formula | |
| CN103845500A (en) | Vitreous opacity and hemorrhage treatment traditional Chinese medicine | |
| CN104095968A (en) | Traditional Chinese medicine for treating heat-retention-in-lung-channel type acne | |
| CN106727749A (en) | Agent disease lamb's-quarters ball in a kind of Chinese medicine for treating leucoderma | |
| CN104161782A (en) | Traditional Chinese medicine for treating taeniasissuis | |
| CN106692923A (en) | Traditional Chinese medicinal formula for treating asthma | |
| CN105560490A (en) | Traditional Chinese medicine formula for lowering cholesterol | |
| CN104162084A (en) | Traditional Chinese medicine for treating mycotic enteritis | |
| CN106822813A (en) | A kind of Traditional chinese medicine medicament formula for treating asthma | |
| CN104138399A (en) | Traditional Chinese medicine for treating varioliform gastritis | |
| CN106822812A (en) | A kind of Traditional chinese medicine medicament formula for treating cold-dampness numbness type gout | |
| CN106822299A (en) | A kind of Traditional chinese medicine medicament formula of norcholesterol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Wang Rongjia Document name: Notification of Acceptance of Patent Application |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Qi Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Qi Document name: Notification of Publication of the Application for Invention |
|
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |